Zhang Xiao-Li, Jia Qian, Lv Lin, Deng Tao, Gao Jian
Department of Gastroenterology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China.
Anticancer Agents Med Chem. 2015;15(6):755-63. doi: 10.2174/1871520615666150202111721.
Recent evidence suggests that a small subset of cells within tumors have 'stem cell-like' characteristics. However, direct proof of the population of liver CSCs remains elusive. Further research is needed to identify cells with stem cell properties in established HCC cell lines. Our previous investigation found that tumor spheres are essentially enriched in CSCs. We hypothesized that chemoresistance in hepatocellular carcinoma (HCC) is due to enrichment of cancer stem cells via the PI3K/Akt pathway. We found that tumor spheres cells formed from HCC cells contained a high percentage of CD90(+) cells, and these cells were more tumorigenic and resistant to doxorubicin (DOX), showing a higher proliferation rate and lower apoptosis rate compared to cells in monolayer culture. Treatment with DOX and PI3K/Akt inhibitor increased apoptosis and reduced viability among cells in the tumorspheres. The expression of p-Akt1 was upregulated in tumorsphere-forming cells treated with DOX but downregulated upon further treatment with the PI3K/Akt inhibitor. Our results demonstrate that HCC cells in tumorspheres with cancer stem cell properties achieve chemoresistance via the PI3K/Akt1 pathway.
最近的证据表明,肿瘤内一小部分细胞具有“干细胞样”特征。然而,肝癌症干细胞群体的直接证据仍然难以捉摸。需要进一步研究以在已建立的肝癌细胞系中鉴定具有干细胞特性的细胞。我们之前的研究发现,肿瘤球主要富集癌症干细胞。我们假设,肝细胞癌(HCC)中的化疗耐药性是由于通过PI3K/Akt途径富集癌症干细胞所致。我们发现,由肝癌细胞形成的肿瘤球细胞含有高比例的CD90(+)细胞,并且这些细胞更具致瘤性且对阿霉素(DOX)耐药,与单层培养的细胞相比,显示出更高的增殖率和更低的凋亡率。用DOX和PI3K/Akt抑制剂处理可增加肿瘤球中细胞的凋亡并降低其活力。在用DOX处理的肿瘤球形成细胞中,p-Akt1的表达上调,但在用PI3K/Akt抑制剂进一步处理后下调。我们的结果表明,具有癌症干细胞特性的肿瘤球中的肝癌细胞通过PI3K/Akt1途径实现化疗耐药。